A Phase I study of ibrutinib combined with rituximab, ifosfamide, carboplatin, and etoposide in patients with relapsed or primary diffuse large B-cell lymphoma Meeting Abstract


Authors: Sauter, C. S.; Matasar, M. J.; Schoder, H.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Zelenetz, A. D.; McCall, S. S.; Miller, S. T.; Courtien, A. I.; Younes, A.; Moskowitz, C. H.
Abstract Title: A Phase I study of ibrutinib combined with rituximab, ifosfamide, carboplatin, and etoposide in patients with relapsed or primary diffuse large B-cell lymphoma
Meeting Title: 14th International Conference on Malignant Lymphoma
Journal Title: Hematological Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2017 Jun 14-17
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2017-06-07
Start Page: 265
End Page: 266
Language: English
ACCESSION: 123459986
DOI: 10.1002/hon.2438_135
PROVIDER: EBSCOhost
PROVIDER: cin20
DOI/URL:
Notes: Meeting Abstract: 275 -- Accession Number: 123459986 -- Entry Date: In Process -- Revision Date: 20170608 -- Publication Type: Article -- Supplement Title: Jun2017 Supplement -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carol Portlock
    206 Portlock
  2. Craig Moskowitz
    407 Moskowitz
  3. Ariela Noy
    368 Noy
  4. Maria Lia Palomba
    439 Palomba
  5. Heiko Schoder
    550 Schoder
  6. Craig Steven Sauter
    335 Sauter
  7. Andrew D Zelenetz
    781 Zelenetz
  8. Matthew J Matasar
    292 Matasar
  9. David J Straus
    360 Straus
  10. Susan J McCall
    16 McCall
  11. Anita Kumar
    195 Kumar
  12. Anas Younes
    320 Younes
  13. Shoshana T Miller
    4 Miller